Form 4RNTXCIK 0001420565
Rein Therapeutics, Inc.
Insider transaction (Form 4) filed .
Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners.
New to the Form 4? What it is and how to read oneFiling facts
- Accession number
- 0001193125-26-220718
- Filer
- Rein Therapeutics, Inc.
- Ticker
- RNTX
- CIK
- 0001420565
- Form type
- Form 4
- Form description
- Insider transaction
- Filed at
- May 13, 2026
- Period of report
- April 30, 2026
- Filing size
- 7.0 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from Rein Therapeutics, Inc.
See all 41 filings from Rein Therapeutics, Inc. →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1420565/000119312526220718/0001193125-26-220718-index.htm ↗Filer's full EDGAR submission history
EDGAR · Rein Therapeutics, Inc. (0001420565) ↗SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.